Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
International Journal of Hematology|June 5, 2012
Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508Yoshitoyo Kagami, Kuniaki Itoh, Kensei Tobinai, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|March 18, 2021
Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study - JCOG0108ATomohiro Kinoshita, Takashi Watanabe, Kuniaki Itoh, et al.
The Lancet. Haematology|November 4, 2018
Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trialTakashi Watanabe, Kensei Tobinai, Masashi Wakabayashi, et al.
International Journal of Hematology|January 31, 2006
A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203Fumi Mizoroki, Yuko Hirose, Masayuki Sano, et al.
Cancer Science|July 24, 2012
Phase I/II study of decitabine in patients with myelodysplastic syndrome: a multi-center study in JapanYasuhiro Oki, Yutaka Kondo, Kazuhito Yamamoto, et al.
International Journal of Hematology|December 24, 2004
A randomized controlled trial investigating the survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002Tomohiro Kinoshita, Tomomitsu Hotta, Kensei Tobinai, et al.
Annals of Hematology|January 27, 2024
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601Kazuyuki Shimada, Ken Ohmachi, Ryunosuke Machida, et al.
Cancer Science|June 1, 2011
Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromesToshiki Uchida, Yoshiaki Ogawa, Yukio Kobayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2005
Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphomaKensei Tobinai, Takashi Watanabe, Michinori Ogura, et al.
International Journal of Hematology|April 11, 2009
Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia: final results of Japanese multicenter cooperative studyYukio Kobayashi, Kensei Tobinai, Akihiro Takeshita, et al.
Pageof 12